Print this page    •   Back to Web version of article

Draft BHIVA ARV Treatment Guidelines Online for Comment Until 5 March

January/February 2012

The British HIV Association (BHIVA) guidelines for the treatment of HIV-1 positive adults with antiretroviral therapy 2012 are now online in draft.

The scope of this document includes guidance on the initiation of ART in those previously naive to therapy, support of patients on treatment, management of patients experiencing virological failure and recommendations in specific patient populations where other factors need to be taken into consideration.

The Treatment Guidelines Writing Group is grateful for all comments, which will be reviewed before publication.

Comments can be made online at the same URL for the draft document:

www.bhiva.org/treatmentguidelinesconsultation.aspx


Comment

These guidelines have been produced based using a new methodology and grading system compared to earlier documents, and are clearly the result of considerable additional work.

The evidence base is published in a separate 270-page appendix.

Of note, some of the recommendations in the current draft include differences between the BHIVA writing committee and current prescribing by the London consortium.

Readers have until 5 March to comment.

Links to external websites are current at time of posting but not maintained.




This article was provided by HIV i-Base. It is a part of the publication HIV Treatment Bulletin. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/65859/draft-bhiva-arv-treatment-guidelines-online-for-co.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.